REG - Craneware plc - Share Purchase by Chairman Designate

CranewareAnnouncement

18/11/2019 07:05

RNS Number : 6569T
Craneware plc
18 November 2019
 


Craneware plc
("Craneware" or the "Company")
Purchase of Ordinary Shares by Chairman Designate
 
18 November 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, has been informed that on 14 November 2019 incoming Chairman, Will Whitehorn, purchased 1,171 ordinary shares of 1p each in the Company ('Ordinary Shares') at a price of 2,550p per share.
 
Following this purchase, Mr. Whitehorn holds 1,171 Ordinary Shares in the Company, representing 0.004 per cent. of the Company's issued share capital.
 
 
Appendix:
 
PDMR notification: William Whitehorn
 
 



1.         Details of the Restricted Person / person closely associated with him or her




a) Name                                                           


William Whitehorn














2.         Reason for the notification




a) Position / status                                            


Incoming Chairman




b) Initial notification / Amendment                       


Initial notification














3.         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a) Name                                                           


Craneware plc




b) LEI                                                               


213800O2CTJ1YFXNXG05














4.         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted














a) Description of the financial instrument, type of instrument


Ordinary shares of 1p each in the capital of Craneware plc "Ordinary Shares"
























b) Identification code                                         


ISIN GB00B2425G68














c) Nature of the transaction                                


Purchase of Ordinary Shares














d) Price(s) and volume(s)                                   


Volume(s) 1,171, Price(s) £25.50














e) Aggregated information:








                                    i. Aggregated volume           


Aggregate volume(s) 1,171




                                    ii. Price                        


Price(s) £25.50














f) Date of the transaction                       


2019-11-14














g) Place of the transaction                                 


London Stock Exchange (XLON)



 
 
 
 
 
 
 
 
 
For further information, please contact:
 



Craneware plc


Peel Hunt (NOMAD & Joint Broker)               


Investec Bank (Joint Broker)


Alma (Financial PR)




+44 (0)131 550 3100


+44 (0)20 7418 8900


+44 (0)20 7597 5970


+44 (0)203 405 0205




Keith Neilson, CEO


Dan Webster


Patrick Robb


Caroline Forde




Craig Preston, CFO


George Sellar


Sebastian Lawrence


Hilary Buchanan








Guy Pengelley


Henry Reast


Helena Bogle



 
 
About Craneware
 
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
 
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
 
 
 
 
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEADFKFSKNFFF